cancer2024Europe
 

Program Layout

Hosting Organization

World High Technology Society

Overseas Cooperate Medias and Journals

Scientific Program



Day 1 | Day 2 | Day 3

 

 

Session 102: Cancer Genetics, Genomics and Epigenetics

Time: 08:30-12:35, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-09:00

Title : Epigenetics of Developmental Tumors-Teratomas
Dr. Floriana Bulic-Jakus, University of Zagreb, Croatia
09:00-09:25 Title: Towards a Novel Framework for Large Scale RNAseq Data Analysis in Human Health
Dr. Thérèse Commes, Groupe d'Études des Transcriptomes, Université Montpellier 2, France
09:25-09:50 Title : The Role of Genomic Structural Variants in Prognosis and Treatment of Cancer
Dr. James R. Broach Distinguished Professor and Chair, Penn State College of Medicine, USA
09:50-10:15 Title: Dissecting the Molecular Heterogeneity of Young-Onset Colorectal Cancer
Dr. Xin Wang, Associate Professor, The Chinese University of Hong Kong, Hong Kong of China
10:15-10:30 Coffee Break
10:30-10:55 Title: Pancreatic Neoplasm Associated with Pancreaticobiliary Maljunction - A Case Report and A Literature Review
Dr. Masako Ogawa, Ome Municipal General Hospital, Japan 
10:55-11:20 Title : Tumor Suppressive Properties and Genotypic Variations That Are Predictive of Cancer Predisposition to the Meig1 gene
Dr. Jeremy Don, Professor, Bar-Ilan University, Israel
11:20-11:45

Title: Telomere Homeostasis From Colorectal Adenoma to Metastatic Cancer
Dr. Ludmila Vodickova, Institute of Experimental Medicine of the Czech Academy of Sciences, Czech Republic
11:45-12:10

Title: TBD
Dr. Ioannis Papasotiriou, Medical Director, R.G.C.C. INTERNATIONAL GmbH, Switzerland
12:10 Title : TRIM32 Promotes Radioresistance by Disrupting TC45-STAT3 Interaction in Triple-Negative Breast Cancer
Dr. Jianming Tang, Zhejiang Provincial People' s Hospital, People' s Hospital of Hangzhou Medical College, China

 

Session 202: Prognostic and Predictive Biomarkers

Time: 08:30-12:10, July 23, 2023
Chair Dr. Aniruddha Ganguly, Program Director, National Cancer Institute, USA

Time

Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Finding a Potential Prognostic Biomarker with Analyzing A Serum Soluble CD26/DPP4 Titer Variation from Baseline in Cancer Treatment on Patients with CD26+Tumor in Phase I and Phase I/II Clinical Trials by a Humanized anti-CD26 Monoclonal Antibody Therapy 
Dr. Yutaro Kaneko, CEO, Juntendo University, Tokyo, Japan
09:00-09:25 Title: Using an Integrated Multiplexing Approach to Identify Prognostic Biomarkers in Rare Ovarian Granulosa Cell Tumors
Dr. Anna Juncker-Jensen, Senior Scientist,, NeoGenomics,USA
09:25-09:50

Title : Application of Exosomes Multiomics in Cancer Clinical Therapeutics
Dr. Hong Wang, Scientific Manager, The University of Texas MD Anderson Cancer Center, USA
09:50-10:15

Title : Impact of the Major BCR-ABL1 Transcript Type on Clinical and Biological Parameters and Molecular Response in Patients with Chronic Myeloid Leukemia

Dr. Mourad Nachi, Director of Medical Biochemistry and Molecular Biology Laboratory, Ahmed Ben Bella University of Oran, Algeria
10:15-10:30 Coffee Break
10:30-10:55 Title: TBD
Dr. Aniruddha Ganguly, Program Director, National Cancer Institute, USA
10:55-11:20 Title: TBD
Dr. Safana S. Al Saidi, Clinical Biochemist and Section Head of Quality Research. Ministry of Health, Oman
11:20-11:45 Title: In-vivo Therapeutic Efficacy Evaluation of Cancer Theragnostic System
Dr. Livesey David Olerile, Shandong University, China
11:45-12:10 Title : The Role of the Notch system in Aggressive Pituitary Tumors
Dr. Carolina Cristina, Universidad Nacional del Noroeste de la Provincia de Buenos Aires, Argentina

 

Session 302: Innovation and Biomarkers in Cancer Drug Development

Time: 08:30-12:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-09:00 Title: TBD
Dr. Tao Ren, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, China
09:00-09:25 Title : BCL9 regulates CD226 and CD96 Checkpoints of CD8+ T Cells in Colorectal Cancer
 Dr. Di Zhu,
Researcher, Department of Pharmacology, School of Pharmacy and Minhang Hospital, Fudan University, China
09:25-09:50 Title: The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil
Dr. Wania Cristina da Silva, Federal University of Minas Gerais, Brazil
09:50-10:15 Speech Opportunity Available
10:15-10:30 Coffee Break
10:30-10:55

Title :PRMT5 inhibitor JNJ-64619178

Dr. Lijs Beke, Principal Scientist, Janssen Research and Development, Belgium
10:55-11:20 Title: Vaccination with a GnRH Peptide Analogue Associated to Castrate Levels of Testosterone and Prostate Specific Antigen Reduction in men with Advanced Prostate Cancer
Dr. Jesús A. Junco, Center for Genetic Engineering and Biotechnology of Camaguey, Cuba
11:20-11:45 Title : Significant Structural Transition in Potassium Formed Human c-Myc Promoter G Quadruplex in Upon Peptide Binding in K
Dr. Sarika Saxena, Associate Professor, Amity University, India
11:45-12:10 Title: Rapid Diagnosis of Antimicrobial Susceptibility Testing on Septic Patients
Dr. Cidalia Pina-Vaz, CSO and Board Member, Faculty of Medicine of Porto University, Portugal

 

Session 403: Lung Cancer/Other Thoracic Cancers

Time: 08:30-12:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-09:00 Title: TBD
Dr. Anika Jain, Westmead Hospital, Australia
09:00-09:25 Title: TBD
Dr. Evdokia Pasheva, Professor, Bulgarian Academy of Sciences, Bulgaria
09:25-09:50 Title : Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage II-III Non-Small Cell Lung Cancer
Dr. Shima Sepehri, University Brest, France
09:50-10:15 Title: Immunohistochemical Profile of Control Cell Cycle, Proliferation and Differentiation Proteins of Atypical Epithelium with Diffuse Alveolar Damage Caused by COVID-19 in Comparison with Lepidic Adenocarcinoma
Dr. Nikita Vladimirovich Boriskin, City Hospital ��40, Russia
10:15-10:30 Coffee Break
10:30-10:55 Title : Mature TERATOMA in the Right Ventricle
Dr. Fekede D Agwar, Cardiac Center of Ethiopia, Ethiopia
10:55-11:20 Title : Pulmonary lymphangioleiomyomatosis: A Proposed State of Neoplastic Senescence
Dr. Charles Lombard, A Anatomic Pathology Specialist,  , USA
11:20-11:45 Title : Treatment Strategy in Patient with Non Small Cell Lung Cancer Harboring EGFR Mutation in 2022
Dr. Malika Gamaz, University of Medicine Algiers, Algeria
11:45-12:10 Speech Opportunity Available

 

Session 404: Liver, Pancreatic an Biliary Tract Cancer

Time: 08:30-12:10, July 23, 2023
Chair Dr. Junichi Arita, Associate Professor, University of Tokyo, Japan

Time

Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Hepatic Resections an Liver Transplantation: Signaling Pathways Involved in Protection Against Hepatic Ischemia-Reperfusion Damage and Liver Regeneration Failure and with Potential Tumorigenic Actions
Dr. Carmen Peralta, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Spain
09:00-09:25

Title : The Shanghai International Consensus on Diagnosis and Comprehensive TReatment of Colorectal Liver Metastases (2019)
Dr. Graeme Poston, Professor, University of Liverpool, UK
09:25-09:50 Title: TBD
Dr. Nobuyoshi Mori, St. Luke’s International Hospital, Japan
09:50-10:15 Title: Repeat Resection of Neuroendocrine Liver Metastases And Possibility of Cure 
Dr. Junichi Arita, Associate Professor, University of Tokyo, Japan
10:15-10:30 Coffee Break
10:30-10:55 Title: Systemic Chemotherapy for Soft Tissue Sarcoma Rather than Liver, Pancreatic And Biliary Tract Cancer
Dr. Hiroyuki Narahara, Director of Clinical Research Center, Hyogo Prefectural Nishinomiya Hospital, Japan
10:55-11:20 Title : Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma 
Mr. Ricky Harminder Bhogal, University Hospitals of Birmingham, UK
11:20-11:45 Title: Adjuvant or Neoadjuvant Treatment for Resectable Pancreatic  Ductal Adenocarcinoma
Dr. Nebojsa Manojlovic, Head of Department, Military Medical Academy, Serbia
11:45-12:10

Title: Impact of Viral Burden and Trajectory of Hepatocellular Carcinoma in Armenia
Dr. Hasmik Ghazinyan, Nork Clinical Hospital of Infectious Diseases, Yerevan , Armenia

 

Session 502: Cancer Immunology & Immunotherapy

Time: 08:30-12:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Manufacturing Control of Investigational CAR-T- cell products: Standards, Guidelines and Opportunities
 Dr. Devanjan Sikder,  Associate Director, Memorial Sloan-Kettering Cancer Center, USA
09:00-09:25 Title: Rmored CAR T-Cells: The Next Chapter in CAR-T Cell Cancer Immunotherapy
Dr Astero Klampatsa, Team Leader, The Institute of Cancer Research, UK
09:25-09:50 Title : CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma
Dr. Zhirui Wang, Associate Professor, University of Colorado Anschutz Medical Campus, USA
09:50-10:15 Title : Mechanisms underlying Heterogeneous Outcome of Immune Checkpoint Inhibitors in Mouse HNSCC Models
Dr. Jing H Wang, University of Colorado, Anschutz Medical Campus, USA
10:15-10:30 Coffee Break
10:30-10:55

Title: New Perspectives to Improve the MHC-I Unrestricted Immune Mechanisms against Malignant Tumors
Dr. Tibor Hajto, Professor, Medical University Pecs, Hungary
10:55-11:20 Title: TBD
Dr. Soumaya Kilani-Jaziri, University of Monastir, Tunisia
11:20-11:45

Title: Individuality and Cancer
Dr. Tamara Rubio Gonzalez, Medical University of Granma, Cuba
11:45-12:10 Title: Labyrinthin Moves from Bench-To-Clinic as Both Neo- And Pan-Adenocarcinoma Target
Dr. Michael Babich, Chief Operating Officer, LabyRx Immuno-Oncology, USA

 

Session 602: Pain Management and Clinical Complications

Time: 08:30-12:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-09:00 Title : A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma
Dr. Mireille Langouo Fontsa, Université Libre de Bruxelles, Belgium
09:00-09:25

Title: Innovative Ambulatory Cancer Cancer at MSKCC
Dr. Geema Shetty Masson, Associate Attending Anesthesiologist, Memorial Sloan Kettering Cancer Center, USA
09:25-09:50 Title: The Strategy of Pain Management in Tunisia Based on the Population's Specificity
Dr. Marwa Tlijani, Centre de maternité et de néonatologie de Monastir, Tunisie
09:50-10:15 Title:  Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients - Full Text View - ClinicalTrials.gov
Dr. Aditya Shreenivas, Assistant Professor, Medical College of Wisconsin, USA
10:15-10:30 Coffee Break
10:30-10:55 Title: Emergency Pain Control in the Cancer Patient
Dr. A. Guido Hita, Assistant Professor, University of Texas MD Anderson Cancer Center, USA
10:55-11:20 Title: TBD
Dr. M. Cachemaille, University Hospital Center, Switzerland
11:20-11:45 Title: TBD
Dr. Silvia Franchi, Università degli Studi di Milano, Italy
11:45-12:10 Speech Opportunity Available

 

Session 103: Cancer Metabolism and Metabolic Pathways

Time: 13:30-17:10, July 23, 2023
Chair Dr. Tomasz Brzozowski, Professor, Jagiellonian University Medical College, Poland

Time

Speeches and Speakers
13:30-13:35 Chair's Introduction
13:35-14:00 Speech Opportunity Available
14:00-14:25 Title : pH, Ion Transport in Connection with Metabolism and Invasion of Tumor Cells 
Dr. Laurent Counillon, Professor, Université Nice-Sophia Antipolis, France
14:25-14:50 Title: In Silico Identification of Tumour Metabolism Biomarkers
 Dr. Gabriel F. Calvo, Profesor, Universidad de Castilla-La Mancha, Spain
14:50-15:15 Title: Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
Dr. Da Jung KIM, Seoul National University College of Medicine and Hospital, Korea
15:15-15:30 Coffee Break
15:30-15:55 Title: TBD
Dr. Kwang-Hyun Baek, Professor, CHA University, South Korea
15:55-16:20 Title : Impact of Dyslipidemia and Obesity on the Incidence of Cardiotoxicity in Breast Cancer Patients Treated with Anthracyclines and Trastuzumab
Dr. A. Maaroufi, CHU Ibn Rochd Casablanca, Maroc
16:20-16:45 Title: TBD
Dr. Martin F. Bachmann, University Hospital Bern, Switzerland
17:45-17:10 Speech Opportunity Available

 

Session 203: Next-Generation Cancer Imaging

Time: 13:30-17:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
13:30-13:35 Chair's Introduction
13:35-14:00

Title: Renal Tumor Imaging
Dr. Hasan Aydin, Diskapi Yildirim Beyazit Education and Research Hospital, Turkey
14:00-14:25

Title :Multi-intensity Optimization-Based CT and Cone Beam CT image Registration
Dr. Lisiqi  Xie, Yunnan University, China
14:25-14:50 Title: 68Ga-PSMA PET/CT and mpMRI for Primary Lymph Node Staging of Intermediate to High-Risk Prostate Cancer: Diagnostic Test Accuracy
Dr. Ka Chun Jonathan, University of Oxford, USA
14:50-15:15 Speech Opportunity Available
15:15-15:30 Coffee Break
15:30-15:55 Title: TBD
Dr. Denise Aberle, Professor, UCLA Medical Center, USA
15:55-16:20

Title : Second Cancer Estimation Associated to the Imaging Procedures Associated to Radiotherapy Treatments of Primary Cancers
Dr. B. Sánchez-Nieto, Instituto de Física, Pontificia Universidad Católica de Chile, Chile
16:20-16:45 Title : Imaging Nail tumors on MRI: How to Make Difference
Dr. Sana Boudabbous, Geneva University Hospital, Switzerland
17:45-17:10 Title: TBD
Dr. Pierre Bourgeois, Professor, Université Libre de Bruxelles, Belgium
17:10-17:35 Title : Minimally Invasive Head and Neck Surgery
Dr. Davud B. Sirjani, Associate Professor, Director of Salivary Program, Stanford Stanford University School of Medicine, USA

 

Session 303: Next-Generation Epigenetic Drugs

Time: 13:30-17:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Surgical Treatment of OMD in Daily Clinical Practice
Dr. Paul De Leyn, Chairman Department of Thoracic Surgery, University Hospitals Leuven, Belgium
14:00-14:25 Title: TBD
Dr. Benedict-Tilman Berger, Goethe University Frankfurt, Germany
14:25-14:50 Speech Opportunity Available
14:50-15:15 Speech Opportunity Available
15:15-15:30 Coffee Break
15:30-15:55 Speech Opportunity Available
15:55-16:20 Speech Opportunity Available
16:20-16:45 Speech Opportunity Available
17:45-17:10 Speech Opportunity Available

 

Session 405: Colorectal Cancer

Time: 13:30-17:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
13:30-13:35 Chair's Introduction
13:35-14:00 Title : The Impact of a Routine Extended Standard lymphadenectomy During Liver Surgery for CCC, HCC and Colorectal Liver Metastases 
Dr. Otto Kollmar, Professor, Clarunis University Center for Gastrointestinal and Liver Disease, St. Clara Hospital and University Hospital Basel, Switzerland
14:00-14:25 Title: TBD
Dr. Samuel Debrah, Darlington Memorial Hospital, UK
14:25-14:50 Title : Colorectal Carcinogenesis: A Visit To Uncharted Territories
Dr. Slim Mzoughi, Assistant Professor, Icahn School of Medicine at Mount Sinai, USA
14:50-15:15 Title: Total Neoadjuvant Therapy in Rectal Cancer: A Gray Zone
Dr. Alina Munteanu, Dr. Ion Chiricuta" Oncology Institute, Romania
15:15-15:30 Coffee Break
15:30-15:55 Title: Diagnosis and Treatment of Colorectal  Anastomosis
Dr. Giovanni Milito, Asociate Professor, University of Rome Tor Vergata, Italy
15:55-16:20 Title: Local Resections after Neoadjuvant Treatment in Rectal Cancer
Dr. Javier Ernesto Barreras Gonzalez, Havana Medical University, Cuba
16:20-16:45

Title: Patients with Parkinson's Disease Predict a Lower Incidence of Colorectal Cancer
Dr. Jiayin Tang, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China
17:45-17:10

Title : Prognostic Role of Tetraspanin 32 in Hematological Malignancies
Dr. Katia Mangano, University of Catania, Italy

 

Session 406: Head and Neck Tumors

Time: 13:30-17:10, July 23, 2023
Chair Dr. Thierry Philip, President, Curie Institute, France

Time

Speeches and Speakers
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Ablation Rate and Thyroglobulin Decrease after Low-Dose 131I in Differentiated Thyroid Carcinoma Post-Total Thyroidectomy
Dr. Duong Duc Binh, National Cancer Hospital (K hospital), Hanoi, Vietnam
14:00-14:25 Speech Opportunity Available
14:25-14:50 Title: The Role of Quality Evaluation in the Comprehensive Cancer Infrastructure European Project
Dr. Thierry Philip, President, Curie Institute, France
14:50-15:15 Title: The Impact of Sequencing Human Genome on Novel Drug Design and the Discovery of AZQ (US Patent 4,146,622) Specifically Designed to Shut Off Genes that Cause Brain Cancer
Dr. A. Hameed Khan, Senior Scientist, NCMRR (National Center for Medical Rehabilitation Research), National Institutes of Health (NIH), USA
15:15-15:30 Coffee Break
15:30-15:55 Title: TBD
Dr. Matsunaga Kazuhide, Associate Professor, Osaka University, Japan
15:55-16:20

Title : Pre and Post Chemotherapy Tumor Volumes: New Prognostic Factors in Nasopharyngeal Carcinoma
Dr. Omar Nouri, CHU Habib Bourguiba, Tunisie
16:20-16:45 Title: DM-CHOC-PEN Plus Radiation for Brain Tumors
Dr. Andrew H Rodgers, Dekk Teck , USA
17:45-17:10 Speech Opportunity Available

 

Session 503: Cancer& Stem Cell Therapy

Time: 13:30-17:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
13:30-13:35 Chair's Introduction
13:35-14:00 Title: TBD
Dr. Charalampia Kyriakou, Consultant Haematologist , University College London, UK
14:00-14:25 Title : The Major Pre- and Postmenopausal Estrogens Play Opposing Roles in Obesity-Driven Mammary Inflammation and Breast Cancer Development
Dr. Manuel Picon-Ruiz, University of Granada, Spain
14:25-14:50 Title: Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation with Cocktail Conditioning Regimen for the Treatment of Pediatric Patients with Chronic Active Epstein-Barr virus: a Retrospective Observational Study
Dr. Yuan Sun, Beijing Jingdu Children's Hospital, China
14:50-15:15 Speech Opportunity Available
15:15-15:30 Coffee Break
15:30-15:55 Speech Opportunity Available
15:55-16:20 Speech Opportunity Available
16:20-16:45 Title: TBD
Dr. Partha Roy, Professor, Tissue EngineeringIndian Institute of Technology Roorkee, India
17:45-17:10 Title: TBD
Dr. Sreejith Parameswara Panicker, University of Kerala, India

 

Session 504: Robotic & Surgical Therapy

Time: 13:30-17:10, July 23, 2023
Chair Call for Chair

Time

Speeches and Speakers
13:30-13:35 Chair's Introduction
13:35-14:00 Title: Surgical and Endoscopic Management of Rectal Neuroendocrine Tumors – Hpw Tp Avoid A Mistake
Dr. Marek Szczepkowski, Professor, Bielanski Hospital, Poland
14:00-14:25 Title : Robotic Surgery in Urology 
Dr. Abdulmajeed Aydh, Medical University of Vienna, Austria
14:25-14:50 Title: TBD
Dr. Christakis Damianou, MEDSONIC LTD, Cyprus
14:50-15:15 Title: TBD
Dr. Yan Jia, The Second Hospital of Jilin University, China
15:15-15:30 Coffee Break
15:30-15:55 Speech Opportunity Available
15:55-16:20 Title: Advanced Diagnostic Techniques for Lung Cancer
Dr. Michael J. Simoff, Professor of Medicine, FTA Wayne State University School of Medicine, USA
16:20-16:45 Title : Multidisciplinary Therapy for Far Advanced Abdominal Cance
Dr. Kazuhiro Hiyama, Atago Hospital, Japan
17:45-17:10

Title: Superior Technology of Lung Cancer Surgery: Robotic Surgery
Dr. Anil Gokce,Thoracic Surgeon, University of Health Sciences, Ankara City Hospital, Turkey

 

 

Hosting Organization

Official Travel Agency

 

Media

Partners

Contact Us

Add: Life Science Innovation Center BLD 3-2, 43 Torch Road,
High Tech Park, Dalian, LN 116023, China

irene@whts.org

© 2003-2024 All rights reserved by BIT Congress